Mansouri, Larry
Thorvaldsdottir, Birna http://orcid.org/0000-0001-7372-9925
Sutton, Lesley-Ann
Karakatsoulis, Georgios
Meggendorfer, Manja
Parker, Helen
Nadeu, Ferran http://orcid.org/0000-0003-2910-9440
Brieghel, Christian http://orcid.org/0000-0002-1816-8106
Laidou, Stamatia http://orcid.org/0000-0002-4636-1579
Moia, Riccardo http://orcid.org/0000-0001-7393-1138
Rossi, Davide
Catherwood, Mark
Kotaskova, Jana http://orcid.org/0000-0003-1672-7346
Delgado, Julio
Rodríguez-Vicente, Ana E. http://orcid.org/0000-0001-6516-2172
Benito, Rocío http://orcid.org/0000-0001-9781-4198
Rigolin, Gian Matteo
Bonfiglio, Silvia
Scarfo, Lydia
Mattsson, Mattias
Davis, Zadie http://orcid.org/0000-0001-6959-4853
Gogia, Ajay
Rani, Lata
Baliakas, Panagiotis http://orcid.org/0000-0002-5634-7156
Foroughi-Asl, Hassan http://orcid.org/0000-0002-6925-9040
Jylhä, Cecilia
Skaftason, Aron
Rapado, Inmaculada
Miras, Fatima
Martinez-Lopez, Joaquín
de la Serna, Javier http://orcid.org/0000-0003-3904-1101
Rivas, Jesús María Hernández
Thornton, Patrick
Larráyoz, María José
Calasanz, María José
Fésüs, Viktória
Mátrai, Zoltán
Bödör, Csaba http://orcid.org/0000-0002-0729-692X
Smedby, Karin E.
Espinet, Blanca http://orcid.org/0000-0002-4294-8145
Puiggros, Anna
Gupta, Ritu http://orcid.org/0000-0001-5364-4086
Bullinger, Lars
Bosch, Francesc
Tazón-Vega, Bárbara
Baran-Marszak, Fanny http://orcid.org/0000-0002-3723-2927
Oscier, David
Nguyen-Khac, Florence
Zenz, Thorsten http://orcid.org/0000-0001-7890-9845
Terol, Maria Jose
Cuneo, Antonio
Hernández-Sánchez, María http://orcid.org/0000-0001-9968-2782
Pospisilova, Sarka
Mills, Ken http://orcid.org/0000-0002-6362-4481
Gaidano, Gianluca
Niemann, Carsten U. http://orcid.org/0000-0001-9880-5242
Campo, Elias http://orcid.org/0000-0001-9850-9793
Strefford, Jonathan C. http://orcid.org/0000-0002-0972-2881
Ghia, Paolo http://orcid.org/0000-0003-3750-7342
Stamatopoulos, Kostas http://orcid.org/0000-0001-8529-640X
Rosenquist, Richard http://orcid.org/0000-0002-0211-8788
Article History
Received: 11 October 2022
Revised: 8 December 2022
Accepted: 15 December 2022
First Online: 24 December 2022
Change Date: 12 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-023-01813-3
Competing interests
: PG: Honoraria/advisory board: AbbVie, Acerta/AstraZeneca, Adaptive, ArQule/MSD, BeiGene, CelGene/Juno, Gilead, Janssen, Loxo/Lilly, Sunesis. Research funding: AbbVie, Gilead, Janssen, Novartis, Sunesis; LS: advisory board AbbVie, AstraZeneca, Janssen; RR: honoraria/advisory board: Abbvie, AstraZeneca, Janssen, Illumina and Roche; KS: honoraria/advisory board: AbbVie, Acerta/AstraZeneca, Gilead, Janssen. Research funding: AbbVie, Gilead, Janssen; PB: honoraria from Abbvie, Gilead and Janssen. Research funding from Gilead; GG: Advisory Board/Speaker’s bureau: Janssen, Abbvie, AstraZeneca, Beigene; LB: honoraria/advisory board: Abbvie, Amgen, Astellas, BMS/Celgene, Daiichi Sankyo, Gilead, Hexal, Janssen, Jazz Pharmaceuticals, Menarini, Novartis, Pfizer, Sanofi, Seattle Genetics. Research funding: Bayer, Jazz Pharmaceuticals; GMR: honoraria from Abbvie, AstraZeneca, Gilead and Janssen. Research funding from Gilead: CB: Honoraria/advisory board: AbbVie, Janssen. The other authors declare no competing financial interests.